Skip to content
Search
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Diagnosis
Treatment
Patient Management
Patient Resources
Events
Contributors
Treatment
Emerging Cell-Free Therapies Offer New Hope in Psoriasis Treatment
Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting around 125 million people worldwide, especially in Western countries....
CURATED BY: Lisa Weiss,
MMSc, PA-C
Lisa Weiss,
MMSc, PA-C
Medical and Cosmetic Dermatology Physician Associate, Dermatology and Skin Surgery Center
Read More
Topical TYK2 Inhibitor Reduces Psoriasis by Targeting Keratinocyte Inflammation
Researchers explored the potential of using a selective TYK2 inhibitor, BMS-986165, as a topical treatment for psoriasis—a novel approach compared...
Lisa Weiss,
MMSc, PA-C
Medical and Cosmetic Dermatology Physician Associate, Dermatology and Skin Surgery Center
CURATED BY:
Lisa Weiss,
MMSc, PA-C
Read More >
Promising Phase 3 Results for Icotrokinra: A New Oral Treatment Option
Johnson & Johnson announced promising results from its Phase 3 clinical trials for icotrokinra (JNJ-2113), an investigational oral peptide for...
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
CURATED BY:
Renee Ott,
MSN, CNP
Read More >
Fastest Time to Meaningful Clinical Response for Plaque Psoriasis
Various systemic therapies are available for the treatment of plaque psoriasis, each with distinct mechanisms of action....
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
CURATED BY:
Renee Ott,
MSN, CNP
Read More >
Roflumilast Foam 0.3% Reduces Psoriasis-Related Itch
Roflumilast foam 0.3%, a non-steroidal PDE4 inhibitor, has shown significant promise for treating psoriasis in adults and adolescents aged 12...
Alison Kortz,
PA-C
Physician Associate, Upstate Dermatology
CURATED BY:
Alison Kortz,
PA-C
Read More >
A Once-Daily Patch for Psoriasis
Researchers at the University of Copenhagen have developed a patch designed to make psoriasis treatment easier and more effective....
Alison Kortz,
PA-C
Physician Associate, Upstate Dermatology
CURATED BY:
Alison Kortz,
PA-C
Read More >
Bimekizumab Shows Low Risk of Suicidal Ideation and Depression in Psoriasis Patients
Patients with psoriasis have an increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, an interleukin (IL)-17A and...
Renee Ott,
MSN, CNP
Family Nurse Practitioner, Dermatologists of Central States
CURATED BY:
Renee Ott,
MSN, CNP
Read More >
Load More
Share
